EXoPERT is a biotech company focusing on detecting cancer early by liquid biopsy. Founded in 2018, EXoPERT is developing a Novel Liquid biopsy technology(MCED) that detects cancer at an early stage, and we aim to expand our impact in healthcare through continued research and development.